TGFB1 and glioblastoma: Understanding the complicated molecular mechanisms that regulate EMT, especially through TGF‐β signaling, is essential for developing new therapeutic strategies aimed at reversing EMT and overcoming resistance, ultimately improving the prognosis for GBM patients.